|
|
Georgia CTSA Weekly eRoundup January 8, 2021
|
|
|
UGA Innovation District Seminar Features Georgia CTSA
The UGA Innovation District Seminar Series is a new speaker series to foster innovation, entrepreneurship, creativity and collaboration, and to promote greater synergy. On January 13 from 5:30 – 7:00 PM, Georgia CTSA representatives will discuss the consortium's programs and services, share a few success stories, highlight the translational research tools available through the Innovation Catalyst, and participate in a virtual panel discussion.
|
|
|
|
Georgia CTSA Leaders Provide Recommendations for Community Engagement of African Americans in COVID-19 Era
Georgia CTSA Community Engagement Program Director Tabia Henry Akintobi, PhD, MPH, and Georgia CTSA Community Steering Board members Theresa Jacobs, MD, Darrell Sabbs, and L. Neicey Johnson, JD, RN, BSN, recently published an article receiving media and researchers’ attention titled ‘Community Engagement of African Americans in the Era of COVID-19: Considerations, Challenges, Implications, and Recommendations for Public Health.’
|
|
|
|
ACTT-2 Study Finds Baricitinib Reduces COVID-19 Recovery Time
Promising results from the Adaptive COVID-10 Treatment Trial 2 (ACTT-2) were published in the December 11, 2020 issue of the New England Journal of Medicine. This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The study found the combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced the recovery time for people hospitalized with COVID-19. ACTT-2 Study Team Members include Emory University Hospital Chief of Infectious Diseases and Georgia CTSA investigator Aneesh K. Mehta, MD. Over the past decade, Georgia CTSA Certificate Program in Translational Research (CPTR) Graduate Christina Gavegnano, PhD, Assistant Professor, Emory University School of Medicine has been working with baricitinib for the indication of HIV and shares the internationally issued patent for use for viral infections.
|
|
|
|
Funding (* New Opportunities)
|
|
|
NIH Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
|
|
|
|
Georgia CTSA Pilot Grants RFP – LOI Due January 15
Georgia CTSA’s Pilot Grants program is soliciting proposals that either a.) generate preliminary data and refine research strategies for subsequent extramural grant applications OR b.) develop the best approaches and methodologies to address complex translational and clinical research problems. Awards involving one institution will be up to $40,000 in total direct costs. Awards involving two or more partner institutions will be up to $50,000 in total direct costs, with no more than $40,000 allotted to each institution. The total number of awards to be made is variable based on merit, funds requested, and Pilot Program budget; a maximum of $200,000 will be awarded in this round. Indirect costs will be added after the awards have been made. Full-time faculty from Emory, Georgia Tech, MSM, and UGA may submit proposals.
|
|
|
|
* CDC Funding Announcement for 2021 Special Interest Projects – LOI Due January 25
The Emory Prevention Research Center (EPRC) received notification that CDC has released a funding announcement for 2021 Special Interest Projects. Please use the link to read the NOFO. Special Interest Projects topic areas: projects address physical activity and nutrition, alcohol use, arthritis-appropriate evidence-based interventions, sun safety, cancer screening surveillance, genetic counseling for cancer, epilepsy, lupus, mental health, and hypertension management. An Investigator Interest meeting is January 15 at 11AM. RSVP to lbundy@emory.edu .
|
|
|
|
Emory SCORE Pilot Grants – Due January 25
The Emory Specialized Center of Research Excellence on Sex Differences (Emory SCORE) will fund a variable number of one-year, non-renewable awards ranging from $10K - $30K plus indirect costs, for projects that account for sex as a biological variable when examining key sex influences on health processes and outcomes. Additional awards that are in line with the overlapping missions of Emory SCORE - to strengthen science through accounting for sex - and its partner organizations may be funded in partnership with the Emory Center for AIDS Research (CFAR), the Emory Diabetes Center (EDC), and the Emory Women’s Interagency HIV Study (WIHS). Applications outside these fields are also strongly encouraged.
|
|
|
|
Racial Equity 2030 (Lever for Change & Kellogg Foundation) – Due January 28
This $90 million challenge seeks ideas from anywhere in the world and will scale them over the next decade to transform the systems and institutions that uphold inequity. Solutions may tackle the social, economic, political or institutional inequities we see today. Teams of visionaries, change agents and community leaders from every sector are invited to join. An Informational Meeting via Zoom is December 21 at 1:00PM.
|
|
|
|
* Yerkes Pilot Research Program 2021 – Due January 29
The Yerkes National Primate Research Center is seeking proposals for new pilot research projects that will be funded from the upcoming year of the P51 base grant. 2-3 awards will be awarded. These awards will provide one year of support for up to $70,000 in direct costs. Although the awards are open to all investigators, the NIH Office of Research Infrastructure guidelines require the direct involvement of a Yerkes Core Scientist and encourage applications from researchers outside Yerkes, early career investigators, and those new to the use of non-human primates in research, as well as applications that propose translational research projects.
|
|
|
|
Drug Development Collaboratory (UG3/UH3 Clinical Trial Required) – Due February 9
The purpose of this FOA is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch (TDB) and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies.
|
|
|
|
Burroughs Wellcome Fund (BWF) Innovation in Regulatory Science Awards – Due February 12
Supports academic researchers developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions FDA and others make. The foundation strongly encourages investigators to address regulatory science in areas of the FDA’s strategic priorities including product manufacturing & quality, and food safety & applied nutrition.
|
|
|
|
Chan Zuckerberg Initiative: Visual Proteomics Imaging – Due February 17
Seeks to support 2.5-year challenge grants in the field of visual proteomics. The ability to view protein molecules in cells and monitor changes in their structure, quantity, distribution, and interactions is key to understanding what causes diseases and finding treatments and cures. This grant program will advance technology development for the field of visual proteomics and aim to obtain near-atomic resolution readouts inside the cell. Opportunity is explicitly aimed at technology development. It is not intended to support question-driven basic or translational research, clinical trials, or drug development.
|
|
|
|
* Imlay Innovation Fund RFP – Due February 19
The Imlay Innovation Fund is intended solely to support collaborative activities and pediatric innovation and discovery efforts between Georgia Tech and Children’s, focusing on practical steps that will lead to clinical impact as well as potential commercial opportunities. Two types of projects are eligible for funding: Quick Wins and Innovation Investment. Proposals should focus on solving a problem that will impact care delivery and/or has the potential to positively impact child health.
|
|
|
|
Cures Within Reach: Clinical Repurposing Research to Impact Veterans – Due February 26
This RFP is seeking repurposed treatments to address unmet and high priority medical needs of veterans, including mental health, PTSD and brain injuries, with up to $50,000 in funding for a repurposing clinical trial. We are interested in generic or proprietary drugs, devices, nutraceuticals or diagnostics that could be repurposed to create "new" treatments.
|
|
|
|
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) – Due July 8
This FOA aims to promote partnerships between NCATS intramural investigators (e.g., those conducting research within the labs and clinics of NCATS) and extramural investigators (e.g., those conducting research in labs and clinics outside of the NIH). Specifically, The FOA will provide support for extramural investigators to take advantage of the unique research opportunities available at the NCATS ASPIRE Laboratory within the NCATS Division of Pre-clinical Innovation, and develop innovative ASPIRE modules that will facilitate identification of novel chemical entities targeted towards currently undrugged biological space.
|
|
|
|
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) – Due July 8
This FOA will support intramural - extramural collaborations to develop virtual modules that will enhance the platform’s capabilities. The anticipated outcome includes identification, design, synthesis, and validation of new chemical entities as starting points for drug development of novel targets, and the expansion of chemical space available for drug screening.
|
|
|
|
NCATS/FDA Translational Science Interagency Fellowship – Due January 15
The Translational Science Interagency Fellowship (TSIF) is a new postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA). Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this program will develop skills of value to future careers in academia, the pharmaceutical industry and government.
|
|
|
|
Phlebotomy 101 Introduction to Venipuncture – January 28 & 29
Phlebotomy 101 is a two-day classroom and clinical, hands-on training to venipuncture offered through the Georgia CTSA Clinical Research Centers (GCRCs). The course is offered bi-monthly to research coordinators from Emory, MSM and UGA.
|
|
|
|
Georgia CTSA TL1 (T32-like) Training Grant Clinical & Translational Research Training - Predoc Due February 15, Postdoc Due March 15
The TL1 program is focused on providing innovative didactic and mentored research training to individuals interested in careers that encompass clinical and/or translational research. The TL1 program supports predoctoral and postdoctoral trainees (medical and PhD students, resident and fellow physicians, PhD postdocs, and PharmD residents).
|
|
|
|
Georgia CTSA KL2-Mentored Clinical and Translational Research Scholars Program – Due March 1
The goal of the KL2 Scholars program is to support and enhance career development for junior faculty (MD, PhD, MD/PhD, or PharmD) committed to a career in clinical and/or translational research. The Georgia CTSA is committed to assisting junior faculty at partner institutions to become independent, established, and ethical clinical and/or translational research investigators.
|
|
|
|
Emory BIRCWH Program – Due March 1
The Emory BIRCWH program, short for Building Interdisciplinary Research Careers in Women's Health, is a highly selective career development program for junior faculty interested in women's health research and/or sex/gender science. The ultimate goal of the BIRCWH program is to train junior faculty, through a mentored research and career development experience, to become independent investigators who use novel, interdisciplinary approaches to advance the science of women’s health and sex/gender research. Communicable disease research is one area of focus for the Emory BIRCWH program.
|
|
|
|
Free Online Trainings for Clinical Research Professionals
Georgia CTSA and the University of Southern California Clinical and Translational Science Institute (SC CTSI) have created a new Online Course Catalog with free course and program offerings available to clinical research professionals. Participants earn a certificate or badge with contact hours (continuing education – CE) from an accredited provider upon completion of a course or a program (series of courses). Contact hours can be used to meet requirements for CRP certification renewal. The newest program, “Patient-Centered Drug Development and Real-World Evidence/Data”, is now available online.
|
|
|
|
N3C - COVID-19 Analytics Platform Now Open
Researchers studying COVID-19 now are able to access an innovative new analytics platform that contains clinical data from the electronic health records of people who were tested for the novel coronavirus or who have had related symptoms. Part of the NCATS National COVID Cohort Collaborative (N3C) Data Enclave, the centralized and secure data platform features powerful analytics capabilities for online discovery, visualization and collaboration.
|
|
|
|
All of Us Researcher Workbench Database
The All of Us Research Program at Emory University is excited to announce the launch of the Researcher Workbench Database – a cloud-based platform enabling researchers to execute rapid, hypothesis-driven research on one of the largest and most diverse biomedical datasets of its kind. Researchers may visit the login page to create an account and use their Emory University email account to register.
|
|
|
|
Bench2Market Talks: Intellectual Property Strategy – January 22
Join us at 11:30 AM to learn the fundamentals any scientist or engineer needs to know about intellectual property. Speaker, James Rains, Director of Practice at Georgia Tech, helps attendees demystify the world of patents by explaining the meaning of patentability, freedom to operate, prior art, and discussing patent strategies.
|
|
|
|
Participants Needed for COVID-19 Vaccine and Therapeutic Trials
Adults 18 and older, from all races and ethnicities, are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials.
|
|
|
|
K-Club: Top Ten Pearls for Abstract Submissions – January 11
New to writing abstracts? Register to join K-Club via Zoom at 12:00 PM to learn the Top Ten Pearls for Abstract Submissions!
|
|
|
|
Blue Sky Group: COVID-19 and Cardiovascular Complications – January 13
Join researchers and clinicians from across the Georgia CTSA for a session on COVID-19 and Cardiovascular Complications via Zoom from 4:00 PM – 5:30 PM. Share your experience, learn from others, enjoy opportunities for interdisciplinary networking and find potential collaborators!
|
|
|
|
Emory SOM FAALI Lecture Series: How to Continue Global Research in the Era of Foreign Influence: Raising Awareness of the Unknown – January 14
Have you ever wondered if there is something nefarious going on with global research collaborations? Do you know your collaborator? Are you taking the necessary steps to protect yourself and your research? Tune in to this presentation with Vice President Robert Nobles at 12 PM via Zoom to get a better understanding!
|
|
|
|
Team Science Skill Workshop: Developing Trust and Psychological Safety – January 15
Join Georgia CTSA via Zoom from 12:00 PM -1:30 PM with Associate Professor Jessica L. Wildman, PhD from Florida Institute of Technology. At the end of this session, participants will be able to define trust and psychological safety as they apply within work teams, identify examples of common behaviors that build trust, break trust, and restore trust in work teams. Also, develop strategies to build and maintain trust over time in work teams.
|
|
|
|
COVID FORCE Seminar Series – January 15
Join us via Zoom from 1:00 PM – 12:00 PM to learn more about “COVID-19 Vaccines - How Did We Get Here, Where Are We, and Where Are We Going?” from Professor Evan Anderson, MD.
|
|
|
|
N3C Open House – January 19 – 25
N3C is hosting an Open House to engage CTSA members, newcomers, and the wider translational research community. The event will be kicked off with a 1-hour symposium, followed by a week of open Clinical Domain Team meetings to welcome new collaborators and help them launch their research questions.
|
|
|
|
Qualitative Data Analysis Online Workshop - January 19-23
This online workshop integrates principles with skills for conducting rigorous qualitative data analysis. Synchronous sessions are conducted in real time over Zoom and held at 1pm-4pm EST each day and involve participation in skill building activities, interactive discussions and hands-on software sessions. The price of this QUAL-WORKS course is $750.
|
|
|
|
Pediatric Research Grand Rounds – January 20
Join us via Zoom at 8:00 AM for a Pediatric Grands Rounds session on “Cytokines, Cytokine Signaling & Inflammatory Bowel Disease: Novel Mechanisms and Therapeutic Implications Through the Study of Rare Diseases” with featured speaker Scott Snapper, MD, PhD.
|
|
|
|
Emory SOM FAALI Lecture Series: Promotions and How to Attain One – January 20
Thinking about going up for promotion? Join via Zoom from 5:30 PM – 6:30 PM with Dr. Kathy Griendling to learn about promotions guidelines, requirements for promotion, and strategies for success.
|
|
|
|
Mentored Qualitative Analysis Workshop - January 27
This online mentored session is conducted via Zoom with instructors from 1 PM- 4 PM. It enables you to bring your own project or data and receive expert individual mentoring on qualitative data analysis specific to your project. Prerequisite: participation in a previous QUAL-WORKS Qualitative Data Analysis workshop. The price of this course is $200.
|
|
|
|
CEP Research Symposium – January 29
Join us via Zoom from 8:30 AM to 12:30 PM! The goal of the symposium is for researchers, stakeholders, staff, members, care partners and community members to share and discuss research aimed at empowering people living with mild cognitive impairment (MCI). We will take stock, move forward, encourage collaboration, and synergize the center's progress.
|
|
|
|
CORPH Seminar – February 5
Join CORPH (Clinical Outcomes Research & Public Health) via Zoom from 12:00 PM – 1:00 PM to learn more about “Elevating the Impact of Pediatric Research Through Effective Statistical Collaboration” with Research Assistant Professor Shasha Bai, PhD.
|
|
|
|
Emory SOM FAALI Lecture Series: Pandemic Disruption of the Healthcare Business – February 11
Join us via Zoom from 12:00 PM – 1:00 PM to learn more about Pandemic Disruption of the Healthcare Business with Dr. Bryce Gartland.
|
|
|
|
Emory SOM FAALI Lecture Series: Time Management and Improving Efficiency – February 16
Join us via Zoom from 12:00 PM to 1:00 PM to learn more about Time Management and Improving Efficiency with Professor Andi Shane MD, MPH, MSc, and Professor Marianne Celano, PhD, ABPP.
|
|
|
|
Team Science Skill Series: Leading Teams – February 19
Join Assistant Professor Julie Dinh, PhD from Baruch College for an interactive workshop via Zoom from 12:00 PM – 1:30 PM. At the end of this session, participants will be able to define leadership and its structures within work teams, identify common behaviors that develop and inhibit effective leadership within teams, and develop strategies to maintain leadership in current work environments, including within virtual settings.
|
|
|
|
CORPH Seminar – February 22
Join CORPH (Clinical Outcomes Research & Public Health) via Zoom from 12:00 PM – 1:00 PM to learn more about “Clinical Decision Support Design to Reduce Low-Value Care” with Clinical Informatics Fellow Jonathan M. Beus, MD, MS, FAAP.
|
|
|
|
Southeast Regional Clinical and Translational Conference - March 4 - 5
Hosted by the Georgia CTSA, mark your calendar and plan to virtually join us in 2021 as we bring together researchers from across the region to present the best new clinical and translational research and build collaborative partnerships. We’re excited to announce that Sandro Galea, MD, MPH, DrPH, Boston University, and Cato T. Laurencin, MD, PhD, University of Connecticut, will be our Keynote Speakers.
|
|
|
|
HIV & Aging: Mitochondria to the Metropolis - Population Determinants of Health – April 14 -16
This multidisciplinary conference will provide a venue for all attendees to build scientific partnership and contribute useful knowledge to the quality of care and life of persons aging with HIV. Abstracts due January 15.
|
|
|
|
|